COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells.

MLA

Fujita, Mitsugu, et al. “COX-2 Blockade Suppresses Gliomagenesis by Inhibiting Myeloid-Derived Suppressor Cells.” Cancer Research, vol. 71, no. 7, Apr. 2011, pp. 2664–74. EBSCOhost, https://doi.org/10.1158/0008-5472.CAN-10-3055.

APA

Fujita, M., Kohanbash, G., Fellows-Mayle, W., Hamilton, R. L., Komohara, Y., Decker, S. A., Ohlfest, J. R., & Okada, H. (2011). COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells. Cancer Research, 71(7), 2664–2674. https://doi.org/10.1158/0008-5472.CAN-10-3055

Chicago

Fujita, Mitsugu, Gary Kohanbash, Wendy Fellows-Mayle, Ronald L Hamilton, Yoshihiro Komohara, Stacy A Decker, John R Ohlfest, and Hideho Okada. 2011. “COX-2 Blockade Suppresses Gliomagenesis by Inhibiting Myeloid-Derived Suppressor Cells.” Cancer Research 71 (7): 2664–74. doi:10.1158/0008-5472.CAN-10-3055.